Do environmental estrogens contribute to the decline in male reproductive health?

Clinical Chemistry

Volumn 41, Issue 12 SUPPL., 1995, Pages 1896-1901

  Jensen, Tina Kold ^a   Toppari, Jorma ^b   Keiding, Niels ^c   Skakkebaek, Niels Erik ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

cryptorchidism; diethylstilbestrol; hypospadias; sperm count; testicular cancer

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; PESTICIDE;

CLINICAL TRIAL; CONFERENCE PAPER; CRYPTORCHISM; EXPOSURE; FEMALE; GENITAL MALFORMATION; HUMAN; HYPOSPADIAS; MALE; META ANALYSIS; NONHUMAN; PREGNANCY; SPERMATOZOON COUNT; TESTIS CANCER;

EID: 0028860636     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/41.12.1896     Document Type: Conference Paper

References (68)

1. Toppari J. Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ, et al. Male reproductive health and environmental chemicals with estrogenic effects. Copenhagen: Danish Environmental Protection Agency, 1995:9-166.
2. Nelson CMK, Bunge RG. Semen analysis: evidence for changing parameters of male fertility potential. Fertil Steril 1974;25: 503-7.
3. Bostofte E, Serup J, Rebbe H. Has the fertility of Danish men declined through the years in terms of semen quality? A comparison of semen qualities between 1952 and 1972. Int J Fertil 1983:28:91-5.
4. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. Br Med J 1992;305:609-13.
5. Suominen J, Vierula M. Semen quality of Finnish men. Br Med J 1993;306:1579.
6. Farrow S. Falling sperm quality: fact or fiction [Editorial]? Br Med J 1994;309:1-2.
7. Bromwich P, Cohen J, Stewart I, Walker A. Decline in sperm counts: an artefact of changed reference range of "normal"? Br Med J 1994;309:19-22.
8. Keiding N, Giwercman A, Carlsen E, Skakkebaek NE. Falling sperm quality [Letter]. Br Med J 1994;309:131.
9. Skakkebaek NE, Keiding N. Changes in semen and the testis [Letter]. Br Med J 1994;309:1316-7.
10. Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995;332:281-5.
11. Irvine DS. Falling sperm quality [Letter]. Br Med J 1994;309: 476.
12. Van Waeleghem K, De Clercq N, Vermeulen L, Schoonjans F, Comhaire F. Deterioration of sperm quality in young Belgian men during recent decades [Abstract]. Hum Reprod 1994;9(Suppl. 4):73.
13. Forman D, Møller H. Testicular cancer. Cancer Surv 1994; 19/20:323-41.
14. Pike MC, Chilvers CED, Bobrow LG. Classification of testicular cancer in incidence and mortality statistics. Br J Cancer 1987;56:83-5.
15. Boyle P, Kaye SB, Robertson AG. Changes in testicular cancer in Scotland. Eur J Cancer Clin Oncol 1987;23:827-30.
16. Adami H, Bergström R, Möhner M, Zatonski W, Storm H, Ekbom A, et al. Testicular cancer in nine Northern European countries. Int J Cancer 1994;59:33-8.
17. Stone JM, Cruickshank DG, Sandeman TF, Matthews JP. Trebling of the incidence of testicular cancer in Victoria, Australia (1950-1985). Cancer 1991;68:211-9.
18. Pearce N, Sheppard RA, Howard JK, Fraser J, Lilley BM. Time trends and occupational differences in cancer of the testis in New Zealand. Cancer 1987;59:1677-82.
19. Brown LM, Pottern LM, Hoover RN. Prenatal and perinatal risk factors for testicular cancer. Cancer Res 1986;46:4812-6.
20. Halevi HS. Congenital malformations in Israel. Br J Prev Soc Med 1967;21:66-77.
21. Mital VK, Garg BK. Undescended testicle. Indian J Pediatr 1972;39:171-4.
22. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, CO: Publishing Sciences Group, 1977.
23. Mau G, Schnakenburg KV. Maldescent of the testes: an epidemiological study. Eur J Pediatr 1977;126:77-84.
24. Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR. Prevalence and natural history of cryptorchidism. Pediatrics 1993;92:44-9.
25. Scorer CG. The descent of the testis. Arch Dis Child 1964;39: 605-9.
26. Ansell PE, Bennett V, Bull D, Jackson MB, Pike LA, Pike MC, et al. Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. Arch Dis Child 1992;67:892-9.
27. Hohlbein R. Missbildungsfrequenz in Dresden. Zentralbl Gynäkol 1959;18:719-31.
28. Sweet RA, Schrott HG, Kurland R, Culp OS. Study of the incidence of hypospadias in Rochester, Minnesota, 1940-1970, and a case-contol comparison of possible etiologic factors. Mayo Clin Proc 1974;49:52-8.
29. Matlai P, Beral V. Trends in congenital malformations of external genitalia. Lancet 1985;i:108.
30. Czeizel A, Tóth J, Czvenits E. Increased birth prevalence of isolated hypospadias in Hungary. Acta Paediatr Hung 1986;27: 329-37.
31. Källén B, Winberg J. An epidemiological study of hypospadias in Sweden. Acta Paediatr Scand 1982;293(Suppl):1-21.
32. Leung TJ, Baird PA, McGillivray B. Hypospadias in British Columbia. Am J Med Genet 1985;21:39-48.
33. Finley WH, Gustavson KH, Hall TM, Hurst DC, Bargainer CM, Wiedmeyer JA. Birth defects surveillance: Jefferson County, Alabama and Uppsala County, Sweden. South Med J 1994;87: 440-5.
34. Palmlund I, Apfel R, Buitendijk S, Cabau A, Forsberg JG. Effects of diethylstilbestrol (DES) medication during pregnancy: report from a symposium at the 10th International Congress of ISPOG. J Psychosom Obstet Gynaecol 1993;14:71-89.
35. Herbst AL, Scully RE. Adenocarcinoma of the vagina in adolescence: a report of seven cases including six clear cell carcinomas (so-called mesonephromas). Cancer 1970;25:745.
36. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-81.
37. Henderson BE, Benton B, Cosgrove M, Babtista J, Aldrich J, Townsend D, et al. Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics 1976;58:505-7.
38. Gill WB, Schumacher GFB, Bibbo M. Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero. J Urol 1977;117: 477-80.
39. Gill WB, Schumacher GFB, Bibbo M, Straus FHI, Schoenberg HW. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol 1979;122:36-9.
40. McLachlan JA. Rodent models for perinatal exposure to diethylstilbestrol and their relation to human disease in the male. In: Herbst AL, Bern HA, eds. Developmental effects of diethyl-stilbestrol (DES) in pregnancy. New York: Thieme-Stratton, 1981:148-57.
41. Dieckmann WJ, Davis ME, Rynkiewicz LM, Pottinger RE. Does administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 1953;66:1062.
42. Gill WB, Schumacher GFB, Bibbo M. Genital and semen abnormalities in adult males two and one-half decades after in utero exposure to diethylstilbestrol. In: Herbst AL, ed. Intrauterine exposure to diethylstilbestrol in the human. Chicago: American College of Obstetricians and Gynecologists, 1978:53.
43. Whitehead ED, Leiter E. Genital abnormalities and abnormal semen analyses in male patients exposed to diethylstilbestrol in utero. J Urol 1981;125:47-50.
44. Raman-Wilms L, Tseng AL-i, Wighardt S, Einarson TR, Koren G. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol 1995;85:141-9.
45. Beard M, Melton LJ, O'Fallon WM, Noller KL, Benson RC. Cryptorchism and maternal estrogen exposure. Am J Epidemiol 1984;120:707-16.
46. Stenchever MA, Williamson RA, Leonard J, Karp LE, Ley B, Shy K, et al. Possible relationship between in utero diethylstilbestrol exposure and male fertility. Am J Obstet Gynecol 1981; 140:186-93.
47. Andonian RW, Kessler R. Transplacental exposure to diethylstilbestrol in men. Urology 1976;13:276-9.
48. Vessey MP. Epidemiological studies of the effects of diethyl-stilbestrol. IARC Sci Publ 1989;96:335-48.
49. Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer 1979;23:598-602.
50. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983;71:1151-5.
51. Schottenfeld D, Warshauer ME, Sherlock S, Zauber AG, Leder M, Payne R. The epidemiology of testicular cancer in young adults. Am J Epidemiol 1980;112:232-46.
52. Moss AR, Osmond D, Bacchetti P, Torti FM, Gurgin V. Hormonal risk factors in testicular cancer: a case-control study. Am J Epidemiol 1986; 124:39-52.
53. Gershman ST, Stolley PD. A case-control study of testicular cancer using Connecticut tumour registry data. Int J Epidemiol 1988;17:738-42.
54. Colborn T, Clement C. Chemically-induced alterations in sexual and functional development: the wildlife/human connection. Princeton, NJ: Princeton Scientific Publishing, 1992.
55. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect (in press).
56. Facemire CF, Gross TS, Guillette LJJ. Reproductive impairment in the Florida panther: nature or nurture? Environ Health Perspect 1995;103(Suppl. 4):79-86.
57. Guillette LJJ, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 1994;102:680-8.
58. Guillette LJJ, Gross TS, Gross DA, Rooney AA, Percival HF. Gonadal steroidogenesis in vitro from juvenile alligators obtained from contaminated or control lakes. Environ Health Perspect 1995;103:(Suppl. 4):31-6.
59. Kuroda T, Lee MM, Haqq CM, Powell DM, Manganaro TF, Donahoe PK. Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes. Endocrinology 1990;127:1825-32.
60. Hirobe S, He WW, Lee MM, Donahoe PK. Müllerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology 1992;131:854-62.
61. Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987;10:19-28.
62. Yasuda Y, Kihara T, Tanimura T, Nishimura H. Gonadal dysgenesis induced by prenatal exposure to ethinyl estradiol in mice. Teratology 1985;32:219-27.
63. Walker AH, Bernstein L, Warren DW, Warner NE, Zheng X, Henderson BE. The effect of in utero ethinyl oestradiol exposure on the risk of cryptorchid testis and testicular teratoma in mice. Br J Cancer 1990;62:599-602.
64. Yasuda Y, Kihara T, Tanimura T. Effect of ethinyl estradiol on the differentiation of mouse fetal testis. Teratology 1985;32: 113-8.
65. Sharpe RM. Falling sperm counts in men: is there an endocrine cause? J Endocrinol 1993;137:357-60.
66. Hutson JM, Williams MPL, Attah A, Larkins S, Fallat M. Undescended testes remain a dilemma despite recent advances in research. Aust NZ J Surg 1990;60:429-39.
67. Russell LD, Peterson RN. Determination of the elongate spermatid-Sertoli cell ratio in various mammals. J Reprod Fertil 1984;70:635-41.
68. Orth JM, Gunsalus GL, Lamperti AA. Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development. Endocrinology 1988;122:787-94.